Treasury Bond Intervention Lifts Markets as S&P 500 Ends Losing Streak

Key Highlights

• Treasury Department revealed plans to significantly increase purchases of long-term government securities beginning in September, triggering a decline in bond yields
• Bitcoin soared more than 9%, reclaiming the $70,000 threshold for the first time since the beginning of June
• Major equity indexes including the S&P 500, Dow Jones, and Nasdaq Composite each posted 0.2% gains Wednesday, halting a three-session decline
• Minutes from the Federal Reserve’s July policy meeting revealed three committee members voted against holding rates steady, preferring an increase instead
• America’s total national debt exceeded the $40 trillion mark amid escalating tensions with Iran

The cryptocurrency market saw Bitcoin breach the $70,000 level for the first time in over two months following an unexpected announcement from the Treasury Department regarding expanded bond purchasing operations. Equity markets stabilized while government bond yields retreated from recent highs.

Treasury officials confirmed they would expand their acquisition of longer-maturity government securities to at least twice current levels beginning next month. This strategic intervention helped stabilize the bond market after several days of selling pressure that had created headwinds for equity valuations.

Benchmark 10-year Treasury yields declined approximately 5 basis points to settle at 4.65%. The 30-year bond yield experienced a sharper drop of 9 basis points, closing at 5.19%. Declining yields generally provide support for riskier asset classes including equities and digital currencies.

Cryptocurrency markets responded enthusiastically to the Treasury’s move. Bitcoin advanced over 9% during the session, pushing above the psychologically significant $70,000 price point—a level last seen in early June.

Futures contracts indicated modest gains heading into Thursday’s session. S&P 500 futures edged higher in pre-market trading, while Dow futures remained essentially unchanged. Nasdaq-100 futures climbed approximately 0.2%.

Fed Meeting Records Reveal Policy Division

Wednesday afternoon brought the release of Federal Reserve meeting records from the late July gathering. The documents revealed that three monetary policy committee members cast dissenting votes, advocating for a 25-basis-point interest rate increase rather than maintaining current levels.

Multiple policymakers expressed concerns that additional monetary tightening might prove necessary should inflation remain persistently above the central bank’s 2% objective. The Federal Open Market Committee opted to maintain the federal funds rate within its current 3.50% to 3.75% target range during that session.

Federal Reserve Chair Kevin Warsh had previously indicated a preference for allowing financial market conditions to contribute to economic cooling. Treasury Secretary Scott Bessent’s bond market intervention strategy may present challenges to that approach.

Market participants appeared to discount the hawkish undertones in the Fed minutes. The Treasury Department’s bond market stabilization measures exerted greater influence on investor sentiment.

Energy Markets, Geopolitical Tensions, and Fiscal Concerns

Oil prices remained in focus as international crude benchmarks approached $92 per barrel. The advance reflected diminishing expectations for rapid resolution of US-Iran diplomatic tensions. Elevated energy prices could sustain inflationary pressures.

President Trump used his Truth Social platform to announce plans for what he termed “Economic D-Day” targeting Iran, describing forthcoming economic sanctions and international isolation measures as unprecedented in scope.

America’s accumulated national debt surpassed the $40 trillion threshold, representing more than a twofold increase over the past ten years. This fiscal landmark intensified ongoing debates about long-term sustainability of federal borrowing levels.

Among individual equity movers, Moderna shares skyrocketed nearly 177% following disclosure of encouraging clinical trial data for an experimental personalized mRNA-based cancer treatment developed in partnership with Merck. The biotechnology breakthrough provided momentum across the healthcare sector, which advanced 3.5%.

Walmart prepares to release quarterly financial results Thursday morning. Wall Street analysts anticipate solid performance metrics despite expectations for moderating revenue growth rates.